These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Myocardial scintigraphy with 99mTc-pyrophosphate in 150 coronary care unit patients. Lessem J; Johansson BW; Nosslin B Eur J Cardiol; 1976 Dec; 4(4):453-9. PubMed ID: 187427 [TBL] [Abstract][Full Text] [Related]
24. Double-labeling of experimental acute myocardial infarcts with 113mIn- and 99mTc-EDTMP. Holman BL; Jones AG; Davis MA; Askenazi J; Maroko PR J Nucl Med; 1976 Jun; 17(6):508-11. PubMed ID: 817000 [TBL] [Abstract][Full Text] [Related]
28. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium. Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438 [TBL] [Abstract][Full Text] [Related]
29. [Myocardial scintigraphy with technetium 99m pyrophosphate]. Degeorges M; Roucayrol JC; Comet M; Sol C Arch Mal Coeur Vaiss; 1976 Mar; 69(3):247-51. PubMed ID: 189716 [TBL] [Abstract][Full Text] [Related]
31. Dual radionuclide study of myocardial infarction. Relationships between myocardial uptake of potassium-43, technetium-99m stannous pyrophosphate, regional myocardial blood flow and creatine phosphokinase depletion. Zaret B; DiCola VC; Donabedian RK; Puri S; Wolfson S; Freedman GS; Cohen LS Circulation; 1976 Mar; 53(3):422-8. PubMed ID: 174835 [TBL] [Abstract][Full Text] [Related]
32. A critical review of the efficacy of 99mTc pyrophosphate in detecting myocardial infarction in 103 patients. Tetalman MR; Foley LC; Spencer CP; Bishop SP Radiology; 1977 Aug; 124(2):431-2. PubMed ID: 195308 [TBL] [Abstract][Full Text] [Related]
33. The scintigraphic demonstration of acute myocardial infarcts. Holman BL; Lesch M Compr Ther; 1976 Dec; 2(12):45-9. PubMed ID: 187370 [TBL] [Abstract][Full Text] [Related]
34. [Radioisotope diagnosis of acute myocardial infarct--radionuclide angiocardiography and myocardial scanning with 99mTc-pyrophosphate]. Suzuki Y; Okabe S; Tomoda H; Sasamoto H Rinsho Hoshasen; 1977 Jun; 22(6):553-9. PubMed ID: 195104 [No Abstract] [Full Text] [Related]
35. Uptake of Tc-99m pyrophosphate by the lactating breast. Landgarten S J Nucl Med; 1977 Sep; 18(9):943. PubMed ID: 197135 [No Abstract] [Full Text] [Related]
36. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes. Schümichen C; Hohloch M; Hoffmann G Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437 [TBL] [Abstract][Full Text] [Related]
37. [Follow-up with 99mTc-pyrophosphate and myoglobin in myocardial necrosis]. Brianzoni E; Caporicci D; Mori A; Berbellini A; Centioni G; Spaccesi E; Panduri L Boll Soc Ital Cardiol; 1981; 26(10):1037-41. PubMed ID: 6295419 [No Abstract] [Full Text] [Related]
38. Scintillation camera imaging of acute myocardial infarction using technetiun-99m stannous pyrophosphate: a clinical trial. Kelly RJ; Cowan RJ; Maynard CD; Headley RN N C Med J; 1976 Aug; 37(8):427-30. PubMed ID: 184400 [No Abstract] [Full Text] [Related]
39. Technetium-99m-pyrophosphate: studies in vivo and in vitro. Kaye M; Silverton S; Rosenthall L J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947 [TBL] [Abstract][Full Text] [Related]